Who owns the AARVIK THERAPEUTICS trademark?

The AARVIK THERAPEUTICS trademark is owned by Aarvik Therapeutics, Inc..

What class is the AARVIK THERAPEUTICS trademark registered in?

The AARVIK THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for AARVIK THERAPEUTICS?

The USPTO serial number for AARVIK THERAPEUTICS is 90879874.

What is the registration number for AARVIK THERAPEUTICS?

AARVIK THERAPEUTICS is registered under USPTO registration number 8118566.

Sealvo

Home Search: AARVIK THERAPEUTICSAARVIK THERAPEUTICS #90879874

Back

Updated Oct 17, 2026·29 searches this week

View on USPTO TSDR Find similar marks

AAR

USPTO Trademark Record

REGISTERED

AARVIK THERAPEUTICS

SN 90879874·Reg 8118566·Filed Aug 12, 2021

Owner Aarvik Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

AARVIK THERAPEUTICS (Serial No. 90879874), Registration No. 8118566, is a registered US trademark filed on Aug 12, 2021 by Aarvik Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: January 27, 2032

Mark Intelligence

AARVIK THERAPEUTICS (Reg. #8118566) is a registered US trademark that has been protecting its owner, Aarvik Therapeutics, Inc., since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Aug 12, 2021

SERIAL

90879874

REG#

8118566

REGISTERED

Jan 27, 2026

Filing Information

StatusREGISTERED

Filing DateAug 12, 2021

Serial Number90879874

Registration No.8118566

Registration DateJan 27, 2026

Status DateJan 27, 2026

Published for OppositionMay 31, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 31, 2023

First use in commerce: Dec 31, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

57 events

REGISTERED-PRINCIPAL REGISTER

Jan 27, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 27, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 02, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 02, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Dec 27, 2025

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Dec 01, 2025

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Dec 01, 2025

USE AMENDMENT FILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 21, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Oct 21, 2025

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 21, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 29, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

May 28, 2025

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 03, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 GRANTED

Nov 30, 2024

SOU EXTENSION 4 GRANTED

SOU TEAS EXTENSION RECEIVED

Nov 29, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Nov 29, 2024

SOU EXTENSION 4 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 28, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

May 27, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

May 27, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

May 27, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 30, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Nov 28, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Nov 28, 2023

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Nov 28, 2023

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 27, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 25, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 25, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 25, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 29, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

NEW NOA TO ISSUE

Oct 17, 2022

NEW NOA TO ISSUE

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 28, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

NOTICE OF ALLOWANCE CANCELLED

Jul 26, 2022

NOTICE OF ALLOWANCE CANCELLED

PUBLISHED FOR OPPOSITION

May 31, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 31, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

May 31, 2022

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

May 31, 2022

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

May 31, 2022

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 11, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 23, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Apr 20, 2022

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Apr 20, 2022

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Apr 20, 2022

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Apr 20, 2022

EXAMINER'S AMENDMENT ENTERED

PREVIOUS ALLOWANCE COUNT WITHDRAWN

Apr 13, 2022

PREVIOUS ALLOWANCE COUNT WITHDRAWN

WITHDRAWN FROM PUB - OG REVIEW QUERY

Apr 12, 2022

WITHDRAWN FROM PUB - OG REVIEW QUERY

LAW OFFICE PUBLICATION REVIEW COMPLETED

Mar 31, 2022

LAW OFFICE PUBLICATION REVIEW COMPLETED

ASSIGNED TO LIE

Mar 30, 2022

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 26, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 24, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 23, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 23, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Mar 17, 2022

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 17, 2022

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 17, 2022

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 10, 2022

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 04, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Aug 16, 2021

NEW APPLICATION ENTERED

Other Marks by Aarvik Therapeutics, Inc.

Additional USPTO filings from the same owner.

AQU

AQUALINK

99686197

Aarvik Therapeutics, Inc.

PENDING

AQU

AQUACYS

99663191

Aarvik Therapeutics, Inc.

PENDING

MUT

MUTTA

97435951

Aarvik Therapeutics, Inc.

PENDING

TET

TETRAMAB

98559594

Aarvik Therapeutics, Inc.

ABANDONED

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

SAP

SAPIENCE THERAPEUTICS

86872810

Sapience Therapeutics, Inc.

REGISTERED

CON

CONSYNANCE THERAPEUTICS

86749993

ConSynance Therapeutics, Inc.

REGISTERED

DEL

DELPHIAN THERAPEUTICS

98830481

Schedule 1 Therapeutics, Inc.

REGISTERED

KEE

KEENOVA THERAPEUTICS

79445783

Mallinckrodt Pharmaceuticals Ireland Limited

REGISTERED

Other Marks by Christopher D. Olszyk, Jr.

Additional USPTO filings handled by the same attorney of record.

FIN

FINANCIAL CARE CONCIERGE

86685427

REGISTERED

STA

STATE HOUSE SESSIONS

88763253

REGISTERED

LOG

LogoMark

88763254

REGISTERED

MCO

M. COHEN AND SONS

99672978

REGISTERED

AARVIK THERAPEUTICS

Run a conflict check

Other Marks by Aarvik Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christopher D. Olszyk, Jr.

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company